Epidermal growth factor receptor exon 20 insertion mutations: are we getting closer to solving the puzzle?

Transl Lung Cancer Res. 2024 Nov 30;13(11):2864-2867. doi: 10.21037/tlcr-24-786. Epub 2024 Nov 12.

Author

Thomas E Stinchcombe¹

Affiliation

¹ Division of Medical Oncology, Duke Cancer Institute, Durham, NC, USA.

No abstract available

Keywords: Clinical trial; epidermal growth factor receptor mutation (EGFR mutation); targeted therapy.

Publication types

Editorial
Comment